PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1201
https://www.valueinhealthjournal.com/article/S1098-3015(11)02763-X/fulltext
Title :
PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02763-X&doi=10.1016/j.jval.2011.08.1201
First page :
A452
Section Title :
Cancer
Open access? :
No
Section Order :
1158